![1]()
News
Opioid use curbed with patient education and lower prescription quantities
June 25, 2019
Postsurgery patients given education on opioids and prescribed fewer tablets took less medication.
![1]()
News
Opioid prescriptions declined 33% over 5 years
June 7, 2019
The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association.
News
Direct pharmacy dispensing of naloxone linked to drop in fatal overdoses
May 6, 2019
But emergency department visits related to opioids increased in new adopters of direct authority laws.
News
Only 1.5% of individuals at high risk of opioid overdose receive naloxone
May 3, 2019
“Clinicians can address this gap by regularly prescribing naloxone to eligible patients.”
![1]()
News
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing.
News
In pain treatment, racial bias common among physician trainees
April 24, 2019
MILWAUKEE – Most residents and fellows who demonstrated racial bias did not report that race factored into treatment decisions.
![1]()
News
FDA to expand opioid labeling with instructions on proper tapering
April 10, 2019
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
![1]()
News
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
March 27, 2019
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
![1]()
News
Better communication with pharmacists can improve postop pain control
March 27, 2019
A pharmacist advises surgeons to make sure to adjust medications based on preoperative or intraoperative doses to avoid endangering patients by inadvertently doubling up on doses.
![1]()
News
Surge of gabapentinoids for pain lacks supporting evidence
March 25, 2019
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
